Share This Page
Drug Price Trends for cefaclor
✉ Email this page to a colleague
Average Pharmacy Cost for cefaclor
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CEFACLOR 250 MG CAPSULE | 61442-0171-30 | 0.94212 | EACH | 2025-03-19 |
| CEFACLOR 500 MG CAPSULE | 61442-0172-30 | 0.91332 | EACH | 2025-03-19 |
| CEFACLOR 250 MG CAPSULE | 61442-0171-30 | 0.96824 | EACH | 2025-02-19 |
| CEFACLOR 500 MG CAPSULE | 61442-0172-30 | 0.87346 | EACH | 2025-02-19 |
| CEFACLOR 500 MG CAPSULE | 61442-0172-30 | 0.92631 | EACH | 2025-01-22 |
| CEFACLOR 250 MG CAPSULE | 61442-0171-30 | 0.97932 | EACH | 2025-01-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Cefaclor
Overview of Cefaclor
Cefaclor is a second-generation cephalosporin antibiotic, widely used to treat various bacterial infections such as bladder infections, bronchitis, and kidney infections. Here’s a detailed analysis of the market and price projections for cefaclor.
Global Market Size and Growth
The global cefaclor market is anticipated to experience significant growth over the next few years. As of 2024, the global cefaclor market size is estimated to be USD 162.5 million[1].
- Forecasted Growth: The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.50% from 2024 to 2031, reaching USD 221.1 million by 2031[1].
- Alternative Projections: Some reports suggest a higher growth rate, with the market valued at USD 1.76 billion in 2023 and expected to reach USD 2.82 billion by 2031, growing at a CAGR of 6.99% from 2024 to 2031[3].
Regional Market Analysis
The cefaclor market is segmented across various regions, each with its own growth trajectory:
North America
- Market Size: In 2024, North America held a significant share of the global market with a size of USD 65 million[1].
- Growth Rate: The region is expected to grow at a CAGR of 2.7% from 2024 to 2031[1].
- United States: Specifically, the U.S. market was valued at USD 51.29 million in 2024, with a CAGR of 2.5% from 2024 to 2031[1].
- Canada and Mexico: Canada and Mexico had market sizes of USD 7.8 million and USD 5.92 million, respectively, in 2024, with CAGRs of 3.5% and 3.2% from 2024 to 2031[1].
Europe
- Market Size: Europe accounted for more than 30% of the global revenue, with a market size of USD 48.75 million in 2024[1].
- Growth Rate: The European market is expected to grow at a CAGR of 3.0% from 2024 to 2031[1].
Asia Pacific
- Market Size: The Asia Pacific region held around 23% of the global revenue, with a market size of USD 37.38 million in 2024[1].
- Growth Rate: This region is expected to grow at a higher CAGR of 6.5% from 2024 to 2031[1].
Latin America and Middle East & Africa
- Market Size: Latin America and the Middle East & Africa held smaller but significant shares, with market sizes of USD 8.13 million and USD 3.25 million, respectively, in 2024[1].
- Growth Rate: These regions are expected to grow at CAGRs of 3.9% and 4.2%, respectively, from 2024 to 2031[1].
Pricing and Cost Analysis
The cost of cefaclor can vary based on the formulation and dosage:
Oral Capsules
- 250 mg: The cost for a supply of 30 capsules is around $75.43, with a per-unit price of $2.51[2].
- 500 mg: The cost for a supply of 30 capsules is around $138.61, with a per-unit price of $4.62[2].
Oral Powder for Reconstitution
- 250 mg/5 mL: The cost for 150 milliliters is around $598.01, with a per-unit price of $3.99[2].
Oral Tablet, Extended Release
- 500 mg: The cost for 100 tablets is around $1,992.07, with a per-unit price of $19.92[2].
Drivers and Restraints
Drivers
- Increasing Incidence of Bacterial Infections: The rise in bacterial infections globally is a significant driver for the cefaclor market[1][3].
- Awareness of Antibiotic Resistance: The growing awareness of antibiotic resistance has led to an increased demand for effective antibiotics like cefaclor[1].
- Development of New Formulations: Advances in formulations, such as sustained-release tablets, are expected to boost market growth[5].
Restraints
- Antibiotic Resistance: Despite the growing demand, antibiotic resistance remains a significant challenge for the market[1].
- Regulatory Scrutiny: Strict regulatory environments can impact the approval and marketing of new formulations[5].
Market Segmentation
The cefaclor market is segmented by type and application:
By Type
- USP and EP: These standards define the quality and purity of cefaclor, influencing market segmentation[4].
By Application
- Tablets and Capsules: These are the primary forms in which cefaclor is administered[4].
Competitive Landscape
The market is competitive with several key players:
- Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, Fukang, Dongying Pharmaceutical, Alkem, SALUBRIS, LIVZON, CSPC, Covalent Laboratories, LKPC, HPGC, Huafangpharm[4].
Patient Assistance and Copay Programs
While there are no specific patient assistance programs for cefaclor, patients can benefit from general drug discount programs and copay cards:
- Drugs.com Discount Card: This card can save patients up to 80% on prescription medicines, including cefaclor[2].
Key Takeaways
- The global cefaclor market is expected to grow significantly, driven by increasing bacterial infections and the development of new formulations.
- North America, particularly the U.S., holds a major share of the global market.
- The Asia Pacific region is expected to experience the highest growth rate.
- Pricing varies by formulation, with oral capsules and extended-release tablets being common forms.
- The market faces challenges from antibiotic resistance and regulatory scrutiny.
FAQs
What is the current global market size for cefaclor?
The global cefaclor market size was estimated at USD 162.5 million in 2024[1].
What is the expected growth rate of the cefaclor market from 2024 to 2031?
The market is expected to grow at a CAGR of 4.50% from 2024 to 2031[1].
Which region has the highest growth rate for cefaclor?
The Asia Pacific region is expected to grow at a CAGR of 6.5% from 2024 to 2031, making it the region with the highest growth rate[1].
What are the common formulations of cefaclor?
Cefaclor is available in oral capsules, oral powder for reconstitution, and oral extended-release tablets[2].
Are there any patient assistance programs for cefaclor?
There are no specific patient assistance programs for cefaclor, but patients can use general drug discount programs and copay cards[2].
Who are the key players in the cefaclor market?
Key players include Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, and several others[4].
Sources
- Cognitive Market Research: Global Cefaclor Market Report 2024.
- Drugs.com: Cefaclor Prices, Coupons, Copay Cards & Patient Assistance.
- Market Research Intellect: Cefaclor Market Size, Share | Growth Report, 2031.
- Valuates Reports: Cefaclor - Market, Report Size, Worth, Revenue, Growth, Industry.
- Market Research Intellect: Global Cefaclor Sustained Release Tablets Market Size, Trends and Forecast.
More… ↓
